102 related articles for article (PubMed ID: 2384978)
1. Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
Ohtani K; Murakami H; Shibuya O; Kawamura O; Ohi K; Chiba J; Otokawa M; Ueno Y
Jpn J Exp Med; 1990 Apr; 60(2):57-65. PubMed ID: 2384978
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
Krauer KG; McKenzie IF; Pietersz GA
Cancer Res; 1992 Jan; 52(1):132-7. PubMed ID: 1530766
[TBL] [Abstract][Full Text] [Related]
3. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
Hara H; Luo Y; Haruta Y; Seon BK
Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
[TBL] [Abstract][Full Text] [Related]
4. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
Zubler RH; Erard F; Lees RK; Van Laer M; Mingari C; Moretta L; MacDonald HR
J Immunol; 1985 Jun; 134(6):3662-8. PubMed ID: 3886789
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
Rowland AJ; McKenzie IF; Pietersz GA
J Drug Target; 1994; 2(2):113-21. PubMed ID: 8069589
[TBL] [Abstract][Full Text] [Related]
6. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
[TBL] [Abstract][Full Text] [Related]
10. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
Anderson PM; Blazar BR; Bach FH; Ochoa AC
J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
[TBL] [Abstract][Full Text] [Related]
12. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines.
Salem ML
Int Immunopharmacol; 2005 Jun; 5(6):947-60. PubMed ID: 15829411
[TBL] [Abstract][Full Text] [Related]
14. Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.
Kim JA; Averbook BJ; Chambers K; Rothchild K; Kjaergaard J; Papay R; Shu S
Cancer Res; 2001 Mar; 61(5):2031-7. PubMed ID: 11280763
[TBL] [Abstract][Full Text] [Related]
15. Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates.
Pietersz GA; Smyth MJ; McKenzie IF
Cancer Res; 1988 Feb; 48(4):926-31. PubMed ID: 3422182
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biological characterization of conjugates consisting of ricin and a tumor-specific non-internalizing MAb.
Cogliati T; Brusa P; Canevari S; Caldera M; Mezzanzanica D; Dosio F; Cattel L; Colnaghi MI
Anticancer Res; 1991; 11(1):417-21. PubMed ID: 2018380
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
18. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
May KF; Chen L; Zheng P; Liu Y
Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
[TBL] [Abstract][Full Text] [Related]
19. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
Bamezai A; Goldmacher V; Reiser H; Rock KL
J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
[TBL] [Abstract][Full Text] [Related]
20. Effect of Fusarium toxins, T2-toxin and diacetoxyscirpenol on murine T-independent immune responses.
Rosenstein Y; Kretschmer RR; Lafarge-Frayssinet C
Immunology; 1981 Nov; 44(3):555-60. PubMed ID: 6976308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
